Schonfeld Strategic Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,331
Closed -$2.18M 2511
2025
Q3
$2.18M Buy
16,331
+8,863
+119% +$1.08M 0.01% 989
2025
Q2
$929K Buy
7,468
+4,768
+177% +$607K 0.01% 1329
2025
Q1
$344K Buy
+2,700
New +$416K ﹤0.01% 1736
2024
Q4
Sell
-4,259
Closed -$634K 2327
2024
Q3
$634K Sell
4,259
-3,665
-46% -$526K ﹤0.01% 1333
2024
Q2
$999K Buy
+7,924
New +$1.24M 0.01% 1209
2024
Q1
Sell
-9,943
Closed -$1.79M 2342
2023
Q4
$1.79M Buy
+9,943
New +$1.55M 0.01% 835
2023
Q3
Sell
-15,003
Closed -$2.12M 2208
2023
Q2
$2.12M Buy
15,003
+10,703
+249% +$1.72M 0.02% 733
2023
Q1
$724K Sell
4,300
-5,525
-56% -$986K 0.01% 1056
2022
Q4
$1.66M Sell
9,825
-1,131
-10% -$205K 0.01% 905
2022
Q3
$2.05M Buy
+10,956
New +$2.31M 0.02% 846
2022
Q1
Sell
-2,330
Closed -$617K 2872
2021
Q4
$617K Sell
2,330
-495
-18% -$133K 0.01% 1161
2021
Q3
$816K Buy
+2,825
New +$725K 0.01% 1040
2021
Q2
Sell
-1,951
Closed -$379K 2246
2021
Q1
$379K Buy
+1,951
New +$400K ﹤0.01% 1244
2020
Q3
Sell
-3,434
Closed -$424K 1603
2020
Q2
$424K Buy
+3,434
New +$404K 0.01% 867
2019
Q4
Sell
-4,900
Closed -$376K 1461
2019
Q3
$376K Buy
+4,900
New +$429K 0.01% 725
2019
Q1
Sell
-16,896
Closed -$891K 1210
2018
Q4
$891K Buy
+16,896
New +$991K 0.03% 502
2018
Q3
Sell
-29,300
Closed -$1.38M 993
2018
Q2
$1.38M Buy
+29,300
New +$1.21M 0.07% 338
2017
Q3
Sell
-125,000
Closed -$5.18M 751
2017
Q2
$5.18M Buy
125,000
+84,513
+209% +$3.21M 0.53% 37
2017
Q1
$1.43M Buy
40,487
+263
+0.7% +$8.33K 0.14% 201
2016
Q4
$1.24M Buy
+40,224
New +$1.24M 0.16% 194

Other funds holding RGEN

Schonfeld Strategic Advisors's RGEN Position: Q4 2025 in Review

Schonfeld Strategic Advisors sold out of Repligen (RGEN) in Q4 2025, closing a stake of 16,331 shares — an estimated $2.18M sold.

Schonfeld Strategic Advisors first reported a position in RGEN in Q4 2016 and held it in 20 quarters. The position peaked at $5.18M in Q2 2017. 473 funds tracked by Wall St. Rank hold RGEN as of Q4 2025.

  • Schonfeld Strategic Advisors reported no remaining Repligen position as of Q4 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 16,331 Repligen shares in Q4 2025, an estimated $2.18M.
  • Schonfeld Strategic Advisors first reported a position in Repligen in Q4 2016 and held it in 20 quarters.
  • Schonfeld Strategic Advisors's Repligen position peaked at $5.18M in Q2 2017.
  • 473 funds tracked by Wall St. Rank held Repligen as of Q4 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.